Johnson & Johnson could settle their troubled DePuy ASR hip recall cases at a cost of $4 billion, according to the New York Times. Anonymous sources say the settlement plan has to clear some legal hurdles before becoming reality. A formal announcement from DePuy and J&J is expected in the next few days.
The agreement could award each patient who underwent a revision hip replacement surgery about $350,000. That amount could fluctuate on a case by cases basis depending on a patient’s medical circumstances. However, under the plan leaked to media, patients who have NOT had revision surgery would NOT be eligible for compensation.